Lilly anti-clotting drug gets U.S. priority review
2/21/2008
U.S. regulators have granted
priority review to a closely watched drug for preventing blood
clots being developed by Eli Lilly and Co and Daiichi Sankyo,
the companies said on Thursday.
More: - Read More
Share and enjoy
Post Comment
Entry 1 of 16100
Last Page | Next Page